Industries > Pharma > Organ Preservation Solutions Market Report 2021-2031
Organ Preservation Solutions Market Report 2021-2031
By Solution Type (Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solutions, and Others), By Preservation Technique (Hypothermic Perfusion Preservation, Static Cold Storage, and Others), By Organ Type (Kidneys, Liver, Lungs, Heart, and Other Organs), By End User (Hospitals, Organ Transplant Centers, Specialty Clinics, and Others), By Distribution Channel (Direct Tender, and Retail Sales) and Leading Regional/ Country market analysis
Organ Preservation Solutions Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Organ Preservation Solutions is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 290+ page report provides 370+ tables and 350+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Organ Preservation Solutions Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
• Revenue and growth forecasts from 2021 to 2031 for the Global Organ Preservation Solutions Market By Solution Type
• Viaspan
• Custodiol HTK
• Renograf
• Hypothermosol
• Perfadex
• Lifor
• HBS Solution
• siRNA Transplant Solutions
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Organ Preservation Solutions Market By Preservation Technique
• Hypothermic Perfusion Preservation
• Static Cold Storage
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Organ Preservation Solutions Market By Organ Type
• Kidneys
• Liver
• Lungs
• Heart
• Other Organs
• Revenue and growth forecasts from 2021 to 2031 for the Global Organ Preservation Solutions Market By End User
• Hospitals
• Organ Transplant Centers
• Specialty Clinics
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Organ Preservation Solutions Market By Distribution Channel
• Direct Tender
• Retail Sales
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Organ Preservation Solutions Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Organ Preservation Solutions Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Organ Preservation Solutions Market report helps you
In summary, our 290+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Organ Preservation Solutions Market, with forecasts for Get our report today Organ Preservation Solutions Market Forecast 2021-2031: By Solution Type, Preservation Technique, Organ Type, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Organ Preservation Solutions market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Organ Preservation Solutions Market. Some of the company’s profiled in this report include
• Dr. Franz Köhler Chemie GmbH
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries Ltd
• XVIVO Perfusion AB
• BioLife Solutions, Inc.
• 21st Century Medicine
• Bridge to Life Ltd
• Accord Healthcare
• OrganOx Limited
• Accord Healthcare
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Organ Preservation Solutions Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Organ Preservation Solutions Market Report 2021-2031: By Solution Type (Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solutions, and Others), By Preservation Technique (Hypothermic Perfusion Preservation, Static Cold Storage, and Others), By Organ Type (Kidneys, Liver, Lungs, Heart, and Other Organs), By End User (Hospitals, Organ Transplant Centers, Specialty Clinics, and Others), By Distribution Channel (Direct Tender, and Retail Sales) and Leading Regional/ Country market analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Organ Preservation Solutions Market
2.1. Organ Preservation Solutions Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Organ Preservation Solutions Market Overview
3.1. Global Organ Preservation Solutions Market Size and Forecast By Region
3.2. Global Organ Preservation Solutions Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growing organ transplantation and organ donation around the world
3.3.1.2. Increasing demand of for organ preservation solutions in emerging nations
3.3.1.3. Increasing geriatric population around the world
3.3.1.4. Increasing strategic initiatives in organ preservation solutions market
3.3.2. Market Restraints
3.3.2.1. Stringent regulation
3.3.2.2. High cost of development
3.3.3. Opportunities
3.3.3.1. Increasing focus on healthcare infrastructure
3.3.3.2. Increasing research and development for organ preservation solutions
3.3.4. Challenges
3.3.4.1. Change in organ transplantation and donations policies around the world
3.3.4.2. Increasing investments in organ preservation solutions
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Organ Preservation Solutions Market Analysis and Forecast 2021-2031, By Solution Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Viaspan
4.1.1.1. Viaspan market size and forecast, 2021-2031 (USD Million)
4.1.2. Custodiol HTK
4.1.2.1. Custodiol HTK market size and forecast, 2021-2031 (USD Million)
4.1.3. Renograf
4.1.3.1. Renograf market size and forecast, 2021-2031 (USD Million)
4.1.4. Hypothermosol
4.1.4.1. Hypothermosol market size and forecast, 2021-2031 (USD Million)
4.1.5. Perfadex
4.1.5.1. Perfadex market size and forecast, 2021-2031 (USD Million)
4.1.6. Lifor
4.1.6.1. Lifor market size and forecast, 2021-2031 (USD Million)
4.1.7. HBS Solution
4.1.7.1. HBS Solution market size and forecast, 2021-2031 (USD Million)
4.1.8. SiRNA Transplant Solutions
4.1.8.1. SiRNA Transplant Solutions market size and forecast, 2021-2031 (USD Million)
4.1.9. Others
4.1.9.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 By Preservation Technique (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Hypothermic Perfusion Preservation
5.1.1.1. Hypothermic Perfusion Preservation market size and forecast, 2021-2031 (USD Million)
5.1.2. Static Cold Storage
5.1.2.1. Static Cold Storage market size and forecast, 2021-2031 (USD Million)
5.1.3. Others
5.1.3.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 By Organ Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Kidneys
6.1.1.1. Kidneys market size and forecast, 2021-2031 (USD Million)
6.1.2. Liver
6.1.2.1. Liver market size and forecast, 2021-2031 (USD Million)
6.1.3. Lungs
6.1.3.1. Lungs market size and forecast, 2021-2031 (USD Million)
6.1.4. Heart
6.1.4.1. Heart market size and forecast, 2021-2031 (USD Million)
6.1.5. Other Organs
6.1.5.1. Other Organs market size and forecast, 2021-2031 (USD Million)
7. Global Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Hospitals
7.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
7.1.2. Organ Transplant Centers
7.1.2.1. Organ Transplant Centers market size and forecast, 2021-2031 (USD Million)
7.1.3. Specialty Clinics
7.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.4. Others
7.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Direct Tender
8.1.1.1. Direct Tender market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Sales
8.1.2.1. Retail Sales market size and forecast, 2021-2031 (USD Million)
9. North America Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Organ Preservation Solutions Market Size and Forecast By Solution Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Organ Preservation Solutions Market Size and Forecast By Preservation Technique
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Organ Preservation Solutions Market Size and Forecast By Organ Type
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Organ Preservation Solutions Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Organ Preservation Solutions Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Organ Preservation Solutions Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Organ Preservation Solutions Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Organ Preservation Solutions Market Size and Forecast By Solution Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Organ Preservation Solutions Market Size and Forecast By Preservation Technique
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Organ Preservation Solutions Market Size and Forecast By Organ Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Organ Preservation Solutions Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Organ Preservation Solutions Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Organ Preservation Solutions Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Organ Preservation Solutions Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Organ Preservation Solutions Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Organ Preservation Solutions Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By Solution Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By Preservation Technique
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By Organ Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Organ Preservation Solutions Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Organ Preservation Solutions Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Organ Preservation Solutions Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Organ Preservation Solutions Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Organ Preservation Solutions Market Size and Forecast By Solution Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Organ Preservation Solutions Market Size and Forecast By Preservation Technique
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Organ Preservation Solutions Market Size and Forecast By Organ Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Organ Preservation Solutions Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Organ Preservation Solutions Market Size and Forecast By Distribution Channel
12.7. Brazil Organ Preservation Solutions Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Organ Preservation Solutions Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Organ Preservation Solutions Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Organ Preservation Solutions Market Size and Forecast By Solution Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Organ Preservation Solutions Market Size and Forecast By Preservation Technique
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Organ Preservation Solutions Market Size and Forecast By Organ Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Organ Preservation Solutions Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Organ Preservation Solutions Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Organ Preservation Solutions Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Organ Preservation Solutions Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Organ Preservation Solutions Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Organ Preservation Solutions Market
14.1. Dr. Franz Köhler Chemie GmbH
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Bristol-Myers Squibb Company
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. XVIVO Perfusion AB
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. BioLife Solutions, Inc.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. 21st Century Medicine
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Bridge to Life Ltd
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Accord Healthcare
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. OrganOx Limited
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Takeda Pharmaceutical Company Limited
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Accord Healthcare
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Organ Preservation Solutions Market Drivers & Restraints 2021
Table 7. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 138. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 143. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 147. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 188. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Leading 10 Organ Preservation Solutions Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 362. Dr. Franz Köhler Chemie GmbHProfile 2019 (CEO, HQ, Founded, Website)
Table 363. Dr. Franz Köhler Chemie GmbH Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 364. Bristol-Myers Squibb Company Profile 2019 (CEO, HQ, Founded, Website)
Table 365. Bristol-Myers Squibb Company Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 366. XVIVO Perfusion AB Profile 2019 (CEO, HQ, Founded, Website)
Table 367. XVIVO Perfusion AB.Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 368. BioLife Solutions, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 369. BioLife Solutions, Inc. Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 370. 21st Century Medicine Profile 2019 (CEO, HQ, Founded, Website)
Table 371. 21st Century Medicine Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 372. Bridge to Life Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 373. Bridge to Life Ltd Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 374. Accord Healthcare Profile 2019 (CEO, HQ, Founded, Website)
Table 375. Accord Healthcare Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 376. OrganOx Limited Profile 2019 (CEO, HQ, Founded, Website)
Table 377. OrganOx Limited Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 378. Takeda Pharmaceutical Company Limited Profile 2019 (CEO, HQ, Founded, Website)
Table 379. Takeda Pharmaceutical Company Limited Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 380. Accord Healthcare Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 381. Accord Healthcare Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 382. Other Companies Involved in the Organ Preservation Solutions Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Organ Preservation Solutions Market Drivers & Restraints 2021
Figure 7. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 128. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 133. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 138. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 143. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 188. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Porter’s Five Force Analysis
Companies Mentioned
1. Paragonix Technologies
2. XVIVO Perfusion AB
3. Transmedics
4. Shanghai Genext Medical Technology
5. Waters Medical Systems
6. Preservation Solutions
7. Carnamedica
8. Transplant Biomedicals
9. Organ Assist
10. Institut Georges Lopez
11. Global Transplant Solutions
12. Avionord
13. Organ Preservation Solutions
14. Ebers
15. S.A.L.F.
16. Actelion
17. Affinium Pharmaceutical
18. AiCuris GmbH & Co. KG
19. Alcon
20. Alkem Laboratories
21. Allergan
22. Allied Pharma
23. Apotex
24. APP Pharmaceuticals
25. Aptalis Pharma
26. Aquapharm Biodiscovery
27. Cempra Pharmaceuticals
28. Cipla
29. Claris Lifesciences
30. Cornerstone Biopharma
31. Cornerstone Therapeutics
32. Corona Remedies
33. Eli Lilly
34. Gate Pharma
35. Gilead Sciences
36. GlaxoSmithKline (GSK)
37. Glenmark
38. GlycoVaxyn
39. Hetero
40. Hikma Farmaceutica
41. Hi-Tech Pharma
42. Hospira
43. Macleod Pharmaceuticals
44. Microlabs
45. Nalneva
46. Novartis
47. Novexel
48. Paratek Pharmaceuticals
49. Pfizer
50. Ranbaxy
51. Roche
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Organ Preservation Solutions Market
2.1. Organ Preservation Solutions Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Organ Preservation Solutions Market Overview
3.1. Global Organ Preservation Solutions Market Size and Forecast By Region
3.2. Global Organ Preservation Solutions Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growing organ transplantation and organ donation around the world
3.3.1.2. Increasing demand of for organ preservation solutions in emerging nations
3.3.1.3. Increasing geriatric population around the world
3.3.1.4. Increasing strategic initiatives in organ preservation solutions market
3.3.2. Market Restraints
3.3.2.1. Stringent regulation
3.3.2.2. High cost of development
3.3.3. Opportunities
3.3.3.1. Increasing focus on healthcare infrastructure
3.3.3.2. Increasing research and development for organ preservation solutions
3.3.4. Challenges
3.3.4.1. Change in organ transplantation and donations policies around the world
3.3.4.2. Increasing investments in organ preservation solutions
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Organ Preservation Solutions Market Analysis and Forecast 2021-2031, By Solution Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Viaspan
4.1.1.1. Viaspan market size and forecast, 2021-2031 (USD Million)
4.1.2. Custodiol HTK
4.1.2.1. Custodiol HTK market size and forecast, 2021-2031 (USD Million)
4.1.3. Renograf
4.1.3.1. Renograf market size and forecast, 2021-2031 (USD Million)
4.1.4. Hypothermosol
4.1.4.1. Hypothermosol market size and forecast, 2021-2031 (USD Million)
4.1.5. Perfadex
4.1.5.1. Perfadex market size and forecast, 2021-2031 (USD Million)
4.1.6. Lifor
4.1.6.1. Lifor market size and forecast, 2021-2031 (USD Million)
4.1.7. HBS Solution
4.1.7.1. HBS Solution market size and forecast, 2021-2031 (USD Million)
4.1.8. SiRNA Transplant Solutions
4.1.8.1. SiRNA Transplant Solutions market size and forecast, 2021-2031 (USD Million)
4.1.9. Others
4.1.9.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 By Preservation Technique (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Hypothermic Perfusion Preservation
5.1.1.1. Hypothermic Perfusion Preservation market size and forecast, 2021-2031 (USD Million)
5.1.2. Static Cold Storage
5.1.2.1. Static Cold Storage market size and forecast, 2021-2031 (USD Million)
5.1.3. Others
5.1.3.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 By Organ Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Kidneys
6.1.1.1. Kidneys market size and forecast, 2021-2031 (USD Million)
6.1.2. Liver
6.1.2.1. Liver market size and forecast, 2021-2031 (USD Million)
6.1.3. Lungs
6.1.3.1. Lungs market size and forecast, 2021-2031 (USD Million)
6.1.4. Heart
6.1.4.1. Heart market size and forecast, 2021-2031 (USD Million)
6.1.5. Other Organs
6.1.5.1. Other Organs market size and forecast, 2021-2031 (USD Million)
7. Global Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Hospitals
7.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
7.1.2. Organ Transplant Centers
7.1.2.1. Organ Transplant Centers market size and forecast, 2021-2031 (USD Million)
7.1.3. Specialty Clinics
7.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.4. Others
7.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Direct Tender
8.1.1.1. Direct Tender market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Sales
8.1.2.1. Retail Sales market size and forecast, 2021-2031 (USD Million)
9. North America Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Organ Preservation Solutions Market Size and Forecast By Solution Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Organ Preservation Solutions Market Size and Forecast By Preservation Technique
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Organ Preservation Solutions Market Size and Forecast By Organ Type
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Organ Preservation Solutions Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Organ Preservation Solutions Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Organ Preservation Solutions Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Organ Preservation Solutions Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Organ Preservation Solutions Market Size and Forecast By Solution Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Organ Preservation Solutions Market Size and Forecast By Preservation Technique
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Organ Preservation Solutions Market Size and Forecast By Organ Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Organ Preservation Solutions Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Organ Preservation Solutions Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Organ Preservation Solutions Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Organ Preservation Solutions Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Organ Preservation Solutions Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Organ Preservation Solutions Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By Solution Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By Preservation Technique
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By Organ Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Organ Preservation Solutions Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Organ Preservation Solutions Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Organ Preservation Solutions Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Organ Preservation Solutions Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Organ Preservation Solutions Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Organ Preservation Solutions Market Size and Forecast By Solution Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Organ Preservation Solutions Market Size and Forecast By Preservation Technique
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Organ Preservation Solutions Market Size and Forecast By Organ Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Organ Preservation Solutions Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Organ Preservation Solutions Market Size and Forecast By Distribution Channel
12.7. Brazil Organ Preservation Solutions Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Organ Preservation Solutions Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Organ Preservation Solutions Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Organ Preservation Solutions Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Organ Preservation Solutions Market Size and Forecast By Solution Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Organ Preservation Solutions Market Size and Forecast By Preservation Technique
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Organ Preservation Solutions Market Size and Forecast By Organ Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Organ Preservation Solutions Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Organ Preservation Solutions Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Organ Preservation Solutions Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Organ Preservation Solutions Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Organ Preservation Solutions Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Organ Preservation Solutions Market
14.1. Dr. Franz Köhler Chemie GmbH
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Bristol-Myers Squibb Company
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. XVIVO Perfusion AB
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. BioLife Solutions, Inc.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. 21st Century Medicine
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Bridge to Life Ltd
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Accord Healthcare
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. OrganOx Limited
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Takeda Pharmaceutical Company Limited
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Accord Healthcare
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Organ Preservation Solutions Market Drivers & Restraints 2021
Table 7. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 138. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 143. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 147. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 188. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Leading 10 Organ Preservation Solutions Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 362. Dr. Franz Köhler Chemie GmbHProfile 2019 (CEO, HQ, Founded, Website)
Table 363. Dr. Franz Köhler Chemie GmbH Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 364. Bristol-Myers Squibb Company Profile 2019 (CEO, HQ, Founded, Website)
Table 365. Bristol-Myers Squibb Company Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 366. XVIVO Perfusion AB Profile 2019 (CEO, HQ, Founded, Website)
Table 367. XVIVO Perfusion AB.Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 368. BioLife Solutions, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 369. BioLife Solutions, Inc. Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 370. 21st Century Medicine Profile 2019 (CEO, HQ, Founded, Website)
Table 371. 21st Century Medicine Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 372. Bridge to Life Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 373. Bridge to Life Ltd Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 374. Accord Healthcare Profile 2019 (CEO, HQ, Founded, Website)
Table 375. Accord Healthcare Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 376. OrganOx Limited Profile 2019 (CEO, HQ, Founded, Website)
Table 377. OrganOx Limited Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 378. Takeda Pharmaceutical Company Limited Profile 2019 (CEO, HQ, Founded, Website)
Table 379. Takeda Pharmaceutical Company Limited Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 380. Accord Healthcare Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 381. Accord Healthcare Organ Preservation Solutions Product Offering (Segment, Product Offerings)
Table 382. Other Companies Involved in the Organ Preservation Solutions Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Organ Preservation Solutions Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Organ Preservation Solutions Market Drivers & Restraints 2021
Figure 7. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Viaspan Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Custodiol HTK Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Renograf Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Hypothermosol Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Perfadex Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Lifor Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. HBS Solution Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. SiRNA Transplant Solutions Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Hypothermic Perfusion Preservation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Static Cold Storage Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Kidneys Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Liver Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Lungs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Heart Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Other Organs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Organ Transplant Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 128. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 133. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 138. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 143. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. North America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. North America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. North America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. North America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. North America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. North America Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. US Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Canada Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 188. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. Europe Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. Europe Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Europe Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Europe Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Europe Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Europe Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. UK Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Germany Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. France Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Rest of Europe Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Asia Pacific Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Asia Pacific Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Asia Pacific Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Asia Pacific Organ Preservation Solutions Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. China Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. India Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Japan Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. RoAPAC Organ Preservation Solutions Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Middle East Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Middle East Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Middle East Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Middle East Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Middle East Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Latin America Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Latin America Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Latin America Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Latin America Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Africa Organ Preservation Solutions Market Forecast By Solution Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Africa Organ Preservation Solutions Market Forecast By Preservation Technique 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Africa Organ Preservation Solutions Market Forecast By Organ Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Africa Organ Preservation Solutions Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Organ Preservation Solutions Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Porter’s Five Force Analysis
Companies Mentioned
1. Paragonix Technologies
2. XVIVO Perfusion AB
3. Transmedics
4. Shanghai Genext Medical Technology
5. Waters Medical Systems
6. Preservation Solutions
7. Carnamedica
8. Transplant Biomedicals
9. Organ Assist
10. Institut Georges Lopez
11. Global Transplant Solutions
12. Avionord
13. Organ Preservation Solutions
14. Ebers
15. S.A.L.F.
16. Actelion
17. Affinium Pharmaceutical
18. AiCuris GmbH & Co. KG
19. Alcon
20. Alkem Laboratories
21. Allergan
22. Allied Pharma
23. Apotex
24. APP Pharmaceuticals
25. Aptalis Pharma
26. Aquapharm Biodiscovery
27. Cempra Pharmaceuticals
28. Cipla
29. Claris Lifesciences
30. Cornerstone Biopharma
31. Cornerstone Therapeutics
32. Corona Remedies
33. Eli Lilly
34. Gate Pharma
35. Gilead Sciences
36. GlaxoSmithKline (GSK)
37. Glenmark
38. GlycoVaxyn
39. Hetero
40. Hikma Farmaceutica
41. Hi-Tech Pharma
42. Hospira
43. Macleod Pharmaceuticals
44. Microlabs
45. Nalneva
46. Novartis
47. Novexel
48. Paratek Pharmaceuticals
49. Pfizer
50. Ranbaxy
51. Roche
Companies Profiled in the Report
1. Dr. Franz Köhler Chemie GmbH
2. Bristol-Myers Squibb Company
3. Teva Pharmaceutical Industries Ltd
4. XVIVO Perfusion AB
5. BioLife Solutions, Inc.
6. 21st Century Medicine
7. Bridge to Life Ltd
8. Accord Healthcare
9. OrganOx Limited
10. Accord Healthcare
List of Companies Mentioned in the Report:
1. Paragonix Technologies
2. XVIVO Perfusion AB
3. Transmedics
4. Shanghai Genext Medical Technology
5. Waters Medical Systems
6. Preservation Solutions
7. Carnamedica
8. Transplant Biomedicals
9. Organ Assist
10. Institut Georges Lopez
11. Global Transplant Solutions
12. Avionord
13. Organ Preservation Solutions
14. Ebers
15. S.A.L.F.
16. Actelion
17. Affinium Pharmaceutical
18. AiCuris GmbH & Co. KG
19. Alcon
20. Alkem Laboratories
21. Allergan
22. Allied Pharma
23. Apotex
24. APP Pharmaceuticals
25. Aptalis Pharma
26. Aquapharm Biodiscovery
27. Cempra Pharmaceuticals
28. Cipla
29. Claris Lifesciences
30. Cornerstone Biopharma
31. Cornerstone Therapeutics
32. Corona Remedies
33. Eli Lilly
34. Gate Pharma
35. Gilead Sciences
36. GlaxoSmithKline (GSK)
37. Glenmark
38. GlycoVaxyn
39. Hetero
40. Hikma Farmaceutica
41. Hi-Tech Pharma
42. Hospira
43. Macleod Pharmaceuticals
44. Microlabs
45. Nalneva
46. Novartis
47. Novexel
48. Paratek Pharmaceuticals
49. Pfizer
50. Ranbaxy
51. Roche
List of Organizations Mentioned in the Report:
1. European Medicines Agency (EMA)
2. Food and Drug Administration (FDA)
3. National Institutes of Health (NIH)
4. United Nations (UN)
5. United Nations Office on Drugs and Crime (UNODC)
6. United Nations Statistics Division (UNSD)
7. Statistical Office of the European Union (EUROSTAT)
8. University of Connecticut
9. World Health Organization (WHO)
10. The National Medical Products Administration (NMPA)
11. Indian Council of Medical Research (ICMR)
12. The Therapeutic Goods Administration
13. The Federal Institute for Drugs and Medical Devices (BfArM)
14. Pharmaceuticals and Medical Devices Agency (PMDA)
15. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
16. Ministry of Health, Labour & Welfare(MHLW)
17. Medicines and Healthcare Products Regulatory Agency (MHRA)
18. Centre for Pharmaceutical Administration Health Sciences Authority
19. Central Drug Standard Control Organization (CDSCO)
20. Organisation for Economic Co-operation and Development (OECD)
1. Dr. Franz Köhler Chemie GmbH
2. Bristol-Myers Squibb Company
3. Teva Pharmaceutical Industries Ltd
4. XVIVO Perfusion AB
5. BioLife Solutions, Inc.
6. 21st Century Medicine
7. Bridge to Life Ltd
8. Accord Healthcare
9. OrganOx Limited
10. Accord Healthcare
List of Companies Mentioned in the Report:
1. Paragonix Technologies
2. XVIVO Perfusion AB
3. Transmedics
4. Shanghai Genext Medical Technology
5. Waters Medical Systems
6. Preservation Solutions
7. Carnamedica
8. Transplant Biomedicals
9. Organ Assist
10. Institut Georges Lopez
11. Global Transplant Solutions
12. Avionord
13. Organ Preservation Solutions
14. Ebers
15. S.A.L.F.
16. Actelion
17. Affinium Pharmaceutical
18. AiCuris GmbH & Co. KG
19. Alcon
20. Alkem Laboratories
21. Allergan
22. Allied Pharma
23. Apotex
24. APP Pharmaceuticals
25. Aptalis Pharma
26. Aquapharm Biodiscovery
27. Cempra Pharmaceuticals
28. Cipla
29. Claris Lifesciences
30. Cornerstone Biopharma
31. Cornerstone Therapeutics
32. Corona Remedies
33. Eli Lilly
34. Gate Pharma
35. Gilead Sciences
36. GlaxoSmithKline (GSK)
37. Glenmark
38. GlycoVaxyn
39. Hetero
40. Hikma Farmaceutica
41. Hi-Tech Pharma
42. Hospira
43. Macleod Pharmaceuticals
44. Microlabs
45. Nalneva
46. Novartis
47. Novexel
48. Paratek Pharmaceuticals
49. Pfizer
50. Ranbaxy
51. Roche
List of Organizations Mentioned in the Report:
1. European Medicines Agency (EMA)
2. Food and Drug Administration (FDA)
3. National Institutes of Health (NIH)
4. United Nations (UN)
5. United Nations Office on Drugs and Crime (UNODC)
6. United Nations Statistics Division (UNSD)
7. Statistical Office of the European Union (EUROSTAT)
8. University of Connecticut
9. World Health Organization (WHO)
10. The National Medical Products Administration (NMPA)
11. Indian Council of Medical Research (ICMR)
12. The Therapeutic Goods Administration
13. The Federal Institute for Drugs and Medical Devices (BfArM)
14. Pharmaceuticals and Medical Devices Agency (PMDA)
15. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
16. Ministry of Health, Labour & Welfare(MHLW)
17. Medicines and Healthcare Products Regulatory Agency (MHRA)
18. Centre for Pharmaceutical Administration Health Sciences Authority
19. Central Drug Standard Control Organization (CDSCO)
20. Organisation for Economic Co-operation and Development (OECD)
Download sample pages
Complete the form below to download your free sample pages for Organ Preservation Solutions Market Report 2021-2031Download sample pages
Complete the form below to download your free sample pages for Organ Preservation Solutions Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
